Supreme Court upholds interim relief in JAMP-Jubilant pharmaceutical product dossiers dispute
In the present case, Jubilant Generics alleged Jamp Pharma Canada of misusing its confidential pharmaceutical dossiers. Jubilant claims these were wrongly shared with Indian companies, leading to copyright and trade secret violations.
